Alzheimer's Parkinson's - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Biogen’s aducanumab evokes debate on FDA approvability in Alzheimer’s disease

Alzheimer’s Parkinson’s
Investigators said they’ve only been shown publicly available percentage results, and so are calling for additional baseline information.